BCB Bancorp (BCBP) Reports Q4 Loss of $0.73 Per Share on REO Write-Down
Key Takeaways
- BCB Bancorp reported a net loss of $12.0 million for the fourth quarter of 2025, compared with net income of $3.3 million a year earlier.
- The quarter produced a loss of $0.73 per share, well below the modest profit that analysts had modeled and down from $0.16 per share a year ago.
- Results were driven by a $15.1 million pre-tax write-down of a cannabis-related real estate owned (REO) property, plus higher credit-loss provisioning of $12.2 million.
- Net interest margin (NIM, a measure of lending profitability) improved to 3.03%, up from 2.88% in the prior quarter and 2.53% a year ago.
- Non-accrual loans fell to $63.3 million from $93.5 million in the prior quarter, signaling progress on asset quality.
Earnings Context and Why It Matters
BCB Bancorp (NASDAQ: BCBP), the Bayonne, New Jersey-based holding company for BCB Community Bank, has spent much of 2025 working through elevated credit costs while shrinking its balance sheet to strengthen capital. The fourth-quarter report matters because it shows whether the bank's improving funding costs and widening NIM can finally translate into sustained profitability. For investors, the quarter is a critical checkpoint: the core lending franchise has been stabilizing, but one-time charges and reserve-building have repeatedly offset those gains. This report also closes out a full fiscal year in which the company swung from a profit to a net loss, making the quality and durability of the underlying earnings trend the central question for shareholders. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
For the three months ended December 31, 2025, BCB Bancorp reported a net loss of $12.0 million, or $0.73 per diluted share, compared with net income of $3.3 million, or $0.16 per diluted share, in the fourth quarter of 2024. For the full year 2025, the company posted a net loss of $12.5 million, or $0.84 per diluted share, versus net income of $18.6 million, or $0.99 per diluted share, in 2024.
The quarterly loss was driven primarily by a $15.1 million pre-tax write-down on a cannabis-related REO (real estate owned) property, along with an $8.0 million increase in credit-loss provisioning compared with the year-ago period. The provision for credit losses was $12.2 million in the fourth quarter, up from $4.1 million in the third quarter.
Beneath those charges, the core trend improved. Net interest income rose to $24.2 million from $22.2 million a year earlier, and NIM expanded to 3.03% from 2.53%. The allowance for credit losses (ACL, the reserve set aside to absorb future loan losses) stood at $33.7 million, covering 53.3% of non-accrual loans. Total assets declined 8.9% year over year to $3.28 billion as the bank paid down higher-cost funding, while total deposits were $2.67 billion. On a per-share basis, the reported loss of $0.73 came in far below the roughly $0.21 to $0.22 positive consensus estimate analysts had modeled, marking a significant downside surprise.
Market Reaction and Investor Sentiment
Investor attention following the release centered on separating the one-time REO write-down from the bank's underlying operating performance. The headline loss of $0.73 per share represented a meaningful miss versus consensus, and the efficiency ratio — which measures non-interest expense against revenue — spiked to 120.0% from 62.6% in the prior quarter, reflecting the charge. At the same time, the market received positive signals on funding costs, NIM expansion, and a meaningful decline in non-accrual loans, which management attributed to disciplined resolution of problem credits. Sentiment therefore remains divided: the improving core margin story competes with lingering concerns about credit quality, elevated expenses, and the sustainability of the dividend, which is not currently covered by positive earnings. From what I see, this tension is what many investors are weighing right now.
Forward Outlook and Key Factors to Monitor
The next several quarters will test whether BCB Bancorp can convert its improved NIM and lower funding costs into consistent profitability. The single most important factor to watch is credit quality — specifically, whether non-accrual loans continue their downward trend and whether provisioning normalizes toward more modest levels now that the REO charge is behind the company.
Investors should also monitor deposit costs as the interest-rate environment evolves. Falling funding costs have been a key driver of the margin recovery, and any reversal could slow that momentum. The bank's deliberate balance-sheet reduction, which has lowered total assets and paid down higher-cost brokered deposits and FHLB (Federal Home Loan Bank) advances, is intended to strengthen capital ratios but also means a smaller earning-asset base to generate revenue.
Finally, watch for signs that operating efficiency improves from the elevated fourth-quarter level, as well as any updates on the dividend and on management's progress toward returning to profitability. These factors, rather than any single quarter's headline figure, will likely shape how the market values the stock going forward. I’m watching this closely as the trend develops.
Exploring AI Tools in My Research
In my own analysis of regional banks and earnings events, I frequently rely on Tickeron’s AI Screener to filter comparable names, review technical conditions, and surface sector trends that might otherwise take hours to compile manually. It helps me quickly benchmark performance metrics and identify patterns worth monitoring alongside fundamental reports like this one.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BCBP sees its 50-day moving average cross bearishly below its 200-day moving average
The 50-day moving average for BCBP moved below the 200-day moving average on September 25, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BCBP as a result. In 51 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for BCBP turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 23 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
The Aroon Indicator for BCBP entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.94% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCBP advanced for three days, in 158 of 263 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
BCBP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. BCBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.901) is normal, around the industry mean (1.323). BCBP has a moderately high P/E Ratio (131.583) as compared to the industry average of (23.509). Projected Growth (PEG Ratio) (0.080) is also within normal values, averaging (1.190). Dividend Yield (0.037) settles around the average of (0.030) among similar stocks. BCBP's P/S Ratio (1.419) is slightly lower than the industry average of (3.738).
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a regional bank
Industry RegionalBanks
Advertisement